Please assess the completion status of the following clinical trial:

Trial Title: Zilver PTX Drug-Eluting Peripheral Stent Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* One de novo or restenosed artherosclerotic lesion with \> 50% diameter stenosis~* Reference vessel diameter of 4 - 9 mm~* Rutherford category ≥ 2~* Resting ankle brachial index \< 0.9~Exclusion Criteria:~* Prior stent in the study vessel~* Significant stenosis (\> 50%) or occlusion of inflow tract not successfully treated before the study procedure~* Lacks at least one patent runoff vessel~* Lesions requiring atherectomy, cutting balloons, cryoplasty balloons, or any other advanced device to facilitate stent delivery

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Longer Stents (Type: EXPERIMENTAL): None
- Shorter Stents (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).